Introduction
============

Enterococci are members of the gut microbiota of humans and many animals, and are widespread in the environment. They are also major opportunistic pathogens, mostly causing healthcare-related infections. Among the reasons of their increasing role as nosocomial pathogens, the primary factor is their inherent ability to express and acquire resistance to several antimicrobial agents, with *Enterococcus faecium* emerging as the most therapeutically challenging species ([@B2]).

Oxazolidinones are among the few agents that retain activity against multiresistant strains of enterococci ([@B33]; [@B27]), and the emergence of resistance to these drugs is an issue of notable clinical relevance. Particularly worrisome, due to their potential for horizontal dissemination, are the oxazolidinone resistances caused by *cfr*, encoding a ribosome-modifying enzyme ([@B18]; [@B10]; [@B25]), and *optrA*, encoding a ribosome protection mechanism ([@B37]; [@B39]; [@B32]). Both these genes were found to be associated with a number of different mobile genetic elements.

The *optrA* gene, in particular, was discovered in China in enterococci of human and animal origin isolated in 2005-2014 ([@B37]) where it was detected in different genetic contexts ([@B16]). Since then, *optrA*-positive enterococci have been reported worldwide ([@B23]; [@B9]; [@B14]; [@B28],[@B29]), including Italy, where *optrA* was found --- the first report outside China --- in two bloodstream isolates of *E. faecium* which were also positive for the *cfr* gene, which was not expressed ([@B8]). By further investigating one of those isolates (strain E35048), we noticed that both *optrA* and *cfr* were capable of undergoing excision as minicircles ([@B8]). It is worth noting that among the reported *optrA* protein variants ([@B24]), the one detected in *E. faecium* E35048, named *optrA*~E35048~, is the most divergent, differing by 21 amino acid substitutions from the firstly described *optrA* variant ([@B37]).

The goal of the present work was to investigate the locations, genetic environments, and transferability of the *optrA* and *cfr* resistance genes detected in *E. faecium* E35048. We characterized the genetic contexts and location of *optrA* and *cfr* in *E. faecium* E35048, and found that both genes were co-carried on a plasmid of original structure, named pE35048-oc. This plasmid, which also carried the macrolide resistance gene *erm*(B), shared regions of homology with the well-characterized ([@B31]) and widely distributed ([@B30]; [@B15]) conjugative multiresistance enterococcal plasmid pRE25, but was unable to transfer. In pE35048-oc, the genetic context of *optrA* was different from those so far described in other *optrA*-carrying plasmids, underscoring the plasticity of these resistance regions.

Materials and Methods {#s1}
=====================

Bacterial Strain
----------------

*optrA*- and *cfr*-positive *E. faecium* E35048 (linezolid MIC, 4 μg/ml; tedizolid MIC, 2 μg/ml) was isolated in Italy in 2015 from a blood culture ([@B8]).

WGS and Sequence Analysis
-------------------------

Genomic DNA was extracted using a commercial kit (Sigma-Aldrich, St. Louis, MO). WGS was carried out with the Illumina MiSeq platform (Illumina Inc., San Diego, CA, United States) by using a 2 × 300 paired end approach and a DNA library prepared using Nextera XT DNA Sample Prep Kit (Illumina, San Diego, CA, United States). *De novo* assembly was performed with SPAdes V 3.10.0 ([@B3]) using default parameters. Scaffolds characterized by a length ≤ 300 bp were filtered out. Raw reads were mapped to the filtered scaffolds by using bwa ([@B21]) to check the quality of the assembly. Tentative ordering of selected scaffolds of plasmid origin was performed by BLASTN comparisons of data from WGS to homologous plasmids, and eventually confirmed by PCR approach followed by Sanger sequencing. The ST was determined through the Center for Genomic Epidemiology^[1](#fn01){ref-type="fn"}^. Analysis of insertion sequences was carried out using ISFinder online database^[2](#fn02){ref-type="fn"}^ ([@B34]).

PCR Mapping Experiments
-----------------------

PCR mapping with outward-directed primers topo-FW (5′-GAAGCGACAAGAGCAAGTAT-3′) and optrA-RV (5′- TCTTGAACTACTGATTCTCGG-3′), and Sanger sequencing were used to close the pE35048-oc plasmid sequence.

To investigate the excision of the *optrA* and *cfr* genetic contexts, PCR mapping and sequencing assays were performed using: (i) primer pairs targeting the regions flanking their insertion sites \[orf7-FW (5′-ATTTTTCTTTTGATTTGGTA-3′) and orf14up-RV (5′-AAGTAATCTTTTTTTGTTTT-3′) for the *cfr* genetic context; and orf33-FW (5′-CTTGTTTTGGTGTTGCCCTGG-3′) and orf33-RV (5′-CCACCAAGTAAAAAAGCGG-3′) for the *optrA* genetic context\]; (ii) outward-directed primer pairs designed from *cfr* and *optrA* genes \[cfr-INV (5′-TTGATGACCTAATAAATGGAAGTA-3′) and cfr-FW (5′-ACCTGAGATGTATGGAGAAG-3′); optrA-INV (5′-TTTTTCCACATCCATTTCTACC-3′) and optrA-FW (5′-GAAAAATAACACAGTAAAAGGC-3′)\] (**Figure [1](#F1){ref-type="fig"}**).

![Schematic, but to scale, comparative representation of the linearized forms of plasmid pE35048-oc and plasmid pEF12-0805, both co-carrying *optrA* and *cfr* and sharing a pRE25-related backbone. ORFs are depicted as arrows pointing to the direction of transcription; those common to pRE25 are black, with *erm*(B) spotted; the *erm*(A) gene, not found in pRE25, is green spotted; the ORFs of the *optrA* and the *cfr* contexts are blue and red, respectively, with *optrA* diagonally and *cfr* vertically striped. Minicircle formation by such contexts in pE35048-oc is shown above the plasmid. Other ORFs are white. The primer pairs used are indicated by thin arrows below pE35048-oc. Gray areas between ORF maps denote \> 90% DNA identity.](fmicb-09-02189-g001){#F1}

S1-PFGE, Southern Blotting and Hybridization
--------------------------------------------

Total DNA in agarose gel plugs was digested with S1 nuclease (Thermo Fisher Scientific, Milan, Italy) and separated by PFGE as previously described ([@B4]). After S1-PFGE, DNA was blotted onto positively charged nylon membrane (Ambion-Celbio, Milan, Italy) and hybridized with specific probes ([@B6]). *cfr* and *optrA* probes were obtained by PCR as described elsewhere ([@B37]; [@B7]).

Transformation and Conjugation Experiments
------------------------------------------

Purified plasmids extracted from *E. faecium* E35048 were transformed into the *E. faecalis* JH2-2 recipient by electrotransformation as described previously ([@B7]). The transformants were selected on plates supplemented with florfenicol (10 μg/ml) or erythromycin (10 μg/ml).

In mating experiments, *E. faecium* E35048 was used as the donor. Two florfenicol-susceptible laboratory strains were used as recipients: *E. faecium* 64/3 ([@B38]), and *E. faecalis* JH2-2, both resistant to fusidic acid. Conjugal transfer was performed on a membrane filter. Transconjugants were selected on plates supplemented with florfenicol (10 μg/ml) or erythromycin (10 μg/ml) plus fusidic acid (25 μg/ml).

Curing Assays
-------------

*Enterococcus faecium* E35048 was grown overnight in brain heart agar (BHA) at 42°C for some passages. After each passage a few colonies were picked up, and their DNA was extracted and screened for the presence of the *optrA* and *cfr* genes by PCR with specific primers ([@B8]). In case of negative testing, the strain was regarded as possibly cured and subjected to WGS for confirmation.

Nucleotide Sequence Accession Numbers
-------------------------------------

The complete nucleotide sequence of plasmid pE35048-oc has been assigned to GenBank accession no. MF580438, available under the BioProject ID [PRJNA481862](PRJNA481862).

Results and Discussion
======================

Genome General Features and Resistome of *E. faecium* E35048
------------------------------------------------------------

Assembly of the raw WGS data followed by filtering of low length contigs gave a total of 172 scaffolds (range: 310-137, 266 bp; N50: 41,930 bp; L50: 18; mean coverage: 92X). *E. faecium* E35048 was assigned to ST117, a globally disseminated hospital-adapted clone ([@B17]; [@B35]). Resistome analysis revealed the presence of six acquired resistance genes in addition to the previously described *optrA* and *cfr* genes: *erm*(B) (resistance to macrolides, lincosamides and group B streptogramins), *msr*(C) (resistance to macrolides and group B streptogramins), *tet*(M) (resistance to tetracycline), *aphA* and *aadE* (resistance to aminoglycosides), and *sat4* (resistance to streptothricin).

Characterization of the *optrA*- and *cfr*-Carrying Plasmid pE35048-oc
----------------------------------------------------------------------

The *optrA* and *cfr* genes were found to be linked, 23.1 kb apart in the linearized form, on the same contig, which also contained regions of high similarity (96% nucleotide identity) to the *E. faecalis* plasmid pRE25 (50 kb) (65% coverage) ([@B31]) (GenBank accession no. NC_008445).

PCR and Sanger sequencing using outward-directed primers targeting *orf1* and *optrA* demonstrated that the region containing *optrA* and *cfr* was part of a plasmid which was designated pE35048-oc (**Figure [1](#F1){ref-type="fig"}**). The plasmid was 41,816 bp in size, contained 42 open reading frames (ORFs), and had a G + C content of 35%.

S1-PFGE analysis of genomic DNA extracted from *E. faecium* E35048 showed four plasmids, ranging in size from ∼10 to ∼250 kb (data not shown). Both *optrA* and *cfr* probes hybridized with a plasmid of ∼45 kb, in agreement with sequencing data.

The characteristics of the plasmid ORFs and of their products are detailed in **Table [1](#T1){ref-type="table"}**. In particular, pE35048-oc carried (i) a *repS* gene (*orf6*, corresponding to *orf6* of pRE25), encoding a theta mechanism replication protein responsible for the plasmid replication; (ii) a putative origin of replication downstream of *orf6*; and (iii) a region containing the putative minimal conjugative unit of pRE25, consisting of 15 ORFs (*orf28* to *orf14*, corresponding to *orf24* to *orf39* of pRE25) and the origin of transfer (*oriT*) found upstream of *orf28* ([@B31]). BLASTN analysis showed that the *oriT* nucleotide sequence was shorter in pE35048-oc (only 15 bp vs. 38 bp in pRE25). Compared to pRE25, pE35048-oc lacked (i) the region spanning from *orf41* to *orf5* (two IS*1216* elements probably involved in the rearrangement occurred during plasmid evolution); (ii) *orf10*, i.e., the chloramphenicol resistance *cat* gene; and (iii) *orf11*, another replication gene encoding a rolling-circle replication protein. In addition, compared to pRE25, pE35048-oc carried the *optrA* and *cfr* genes and their respective genetic environments.

###### 

Amino acid sequence identities/similarities of putative proteins encoded by the pE35048-oc (GenBank accession no. [MF580438]{.ul}).

                                                                                                                BLASTP analysis*^a^*                                                                                       
  -------------- -------- --------- ----- --------------------------------------------------------------------- ---------------------------------------------------------------------------------------- ----------------- -----------
  *orfl*         1833     1         610   DNA Topoisomerase III                                                 Type 1 topoisomerase (plasmid) \[*Enterococcus faecium*\]                                YP_976069.1       100 (100)
  *orfl*         3,818    1,932     628   Group II intron                                                       Group II intron reverse transcriptase/maturase \[*Lactobacillales*\]                     WP_010718345.1    100 (100)
  *^b^*Δ*orf3*   4,917    4,555     120   DNA Topoisomerase III                                                 Topoisomerase \[*Bacilli*\]                                                              WP_000108744.1    100 (100)
  *orf4*         5,534    4,917     205   Resolvase                                                             Resolvase (plasmid) \[*E. faecalis*\]                                                    YP_003864109.1    99 (100)
  *orf5*         5,718    5,548     56                                                                          Hypothetical protein pRE25p07 (plasmid) \[*E. faecalis*\]                                YP_783891.1       98 (100)
  *orf6*         7,557    6,067     496   Replication protein                                                   Replication protein (plasmid) \[*E. faecium*\]                                           NP_044463.1       100 (100)
  *orf7*         8,213    7,941     90    Transcriptional regulator                                             CopS (plasmid) \[*Streptococcus pyogenes*\]                                              YP_232751.1       100 (100)
  Δ*orf8*        8,901    8,446     151   Responsible for lincomycin resistance                                 Lincosamide nucleotidyltransferase (plasmid) \[*E. faecium*\]                            ARQ19308.1        99 (100)
  *orf9*         9,772    8,873     299   Transposase                                                           Transposase \[*Streptococcus suis*\]                                                     AGO02197.1        100 (100)
  *orf10*        10,443   9,769     224   Transposase                                                           IS3 family transposase \[*E. faecalis*\]                                                 WP_013330754.1    100 (100)
  *orf11*        11,867   10,809    352   23S ribosomal RNA methyltransferase                                   Cfr family 23S ribosomal RNA methyltransferase \[*Staphylococcus aureus*\]               WP_001835153.1    100 (100)
  *orf12*        13,177   12,278    299   Transposase                                                           Transposase \[*S. suis*\]                                                                AGO02197.1        100 (100)
  *orf13*        13,848   13,174    224   Transposase                                                           IS3 family transposase \[*E. faecalis*\]                                                 WP_013330754.1    100 (100)
  Δ*orf8*        13,921   14,061    47    Responsible for lincomycin resistance                                 Lincomycin resistance protein \[synthetic construct\]                                    AGT57825.1        100 (100)
  *orf14*        15,391   14,531    289                                                                         Hypothetical protein \[*S. suis*\]                                                       WP_079268203.1    96 (98)
  *orf15*        15,822   15, 451   123                                                                         Hypothetical protein \[*Enterococcus casseliflavus*\]                                    WP_032495652.1    99 (99)
  *orf16*        16,546   15,809    245                                                                         Hypothetical protein \[*E. faecalis*\]                                                   WP_012858057.1    100 (100)
  *orf17*        17,768   16,836    310                                                                         Hypothetical protein \[*Enterococcus* sp. HMSC063D12\]                                   WP_070544061.1    100 (100)
  *orf18*        18,693   17,770    307   Membrane protein insertase                                            Hypothetical protein \[*Enterococcus* sp. HMSC063D12\]                                   WP_070544063.1    99 (99)
  *orf19*        20,366   18,711    551   Type IV secretory pathway, VirD4 component, TraG/TraD family ATPase   Hypothetical protein \[*Enterococcus*\]                                                  WP_002325630.1    100 (100)
  *orf20*        20,790   20,359    143                                                                         Ypsilon (plasmid) \[*E. faecalis*\]                                                      YP_003864141.1    100 (100)
  *orf21*        21,346   20,795    183                                                                         Hypothetical protein \[*E. faecium*\]                                                    WP_02 9485693.1   99 (99)
  *orf22*        22,468   21,359    369   Amidase                                                               Putative lytic transglycosylase (plasmid) \[*E. faecalis*\]                              YP_003864139.1    99 (99)
  *orf23*        23,842   22,490    450                                                                         Conjugal transfer protein TraF \[*E. faecium*\]                                          WP_085837474.1    98 (99)
  *orf24*        25,817   23,856    653   Type IV secretory pathway, VirB4 component                            TrsE (plasmid) \[*E. faecalis*\]                                                         YP_003864137.1    100 (100)
  *orf25*        26,457   25,828    209                                                                         Hypothetical protein \[*Enterococcus*\]                                                  WP_002325627.1    99 (100)
  *orf26*        26,857   26,474    127                                                                         AM21 (plasmid) \[*E. faecalis*\]                                                         YP 003305365.1    100 (100)
  *orf27*        27,208   26,876    110   T4SS_CagC                                                             Hypothetical protein pRE25p25 (plasmid) \[*E. faecalis*\]                                YP_783909.1       100 (100)
  *orf28*        29,217   27,232    661   Nickase                                                               Molybdopterin-guanine dinucleotide biosynthesis protein MobA \[*E. faecalis*\]           WP_025186512.1    99 (100)
  *orf29*        29,509   29,808    99                                                                          Hypothetical protein pRE25p23 (plasmid) \[*E. faecalis*\]                                YP_783907.1       100 (100)
  *orf30*        29,811   30,068    85                                                                          Hypothetical protein \[*Enterococcus*\]                                                  WP_021109234.1    100 (100)
  *orf31*        30,927   30,430    165   Molecular chaperone DnaJ                                              Molecular chaperone DnaJ \[*Enterococcus*\]                                              WP_025481726.1    97 (98)
  *orf32*        31,353   30,946    135                                                                         Hypothetical protein pRE25p20 (plasmid) \[*E. faecalis*\]                                YP_783904.1       98 (99)
  Δ*orf33*       32,376   31,705    223   Zeta-toxin                                                            Toxin zeta \[*E. faecium*\]                                                              WP_002300569.1    97 (98)
  *orf34*        33,173   32,412    253   DNA replication protein DnaC                                          AAA family ATPase \[*Proteiniborus ethanoligenes*\]                                      WP_091728780.1    94 (98)
  *orf35*        34,750   33,170    526   IS*Efa15* transposase                                                 Transposase \[*P. ethanoligenes*\]                                                       WP_091728892.1    70 (84)
  *orf36*        36,973   35,006    655   ABC-F type ribosomal protection protein                               ABC-F type ribosomal protection protein OptrA \[*E. faecalis*\]                          WP_078122475.1    97 (98)
  *orf37*        38,100   37,078    340   IS*Efa15* transposase (partial)                                       Transposase \[*Clostridium formicaceticum*\]                                             WP_070963420.1    64 (80)
  Δ*orf33*       38,423   39,199    75    Zeta-toxin                                                            Zeta toxin \[*E. faecium*\]                                                              WP_080440976.1    100 (100)
  *orf38*        38,697   38,425    90    Epsilon-antitoxin                                                     Antidote of epsilon-zeta post-segregational killing system (plasmid) \[*S. pyogenes*\]   YP_232758.1       100 (100)
  *orf39*        38,929   38,714    71    Omega-repressor                                                       Transcriptional repressor (plasmid) \[*S. pyogenes*\]                                    YP_232757.1       99 (100)
  *orf40*        39,917   39,021    298   ParA putative ATPase                                                  Chromosome partitioning protein ParA \[*S. suis*\]                                       WP_0023 87620.1   100 (100)
  *orf41*        40,445   40,314    43                                                                          Hypothetical protein (plasmid) \[*Pediococcus acidilactici*\]                            WP_002321978.1    100 (100)
  *orf42*        41,187   40,450    245   23S rRNA (adenine(2058)-N(6)) methyltransferase                       23S rRNA (adenine(2058)-N(6))-methyltransferase Erm(B) \[*S. suis*\]                     WP_024418925.1    99 (100)

a

For each ORF, only the most significant identity detected is listed.

b

Δ represents a truncated ORF.

The *optrA* context (5,850 bp) consisted of the *optrA~E35048~* gene followed by a novel insertion sequence of the IS*21* family, named IS*Efa15*. Consistently with other members of this family ([@B5]), IS*Efa15* included two CDS encoding a transposase and a helper protein, and was bounded by 11-bp imperfect inverted repeats (IRL 5′-TGTTTATGATA-3′ and IRR 5′-TGTATTTGTCA-3′). A truncated copy of IS*Efa15*, named IS*Efa15^∗^*, was present also upstream of *optrA* gene. This *optrA* context was flanked by 5-bp target site duplications (5′-CTAAT-3′) suggesting its mobilization as a composite transposon, named Tn*6628* (**Figure [1](#F1){ref-type="fig"}**). This transposon was previously shown to form circular intermediate (3,350 bp) including *optrA* and the truncated copy of IS*Efa15* ([@B8]).

The proposed role of IS*1216* in the dissemination of *optrA* among different types of enterococcal plasmids ([@B16]) is likely to be true also for other transposase genes. The *optrA* context was located downstream of the *erm*(B) gene (*orf15* of pRE25) and was integrated into *orf33* (*orf19* of pRE25, which encodes the ζ toxin protein of the ω-ε-ζ toxin/antitoxin system). This integration inactivates ζ toxin encoded by *orf33*, a condition that could prevent the correct partitioning of pE35048-oc and lead to the appearance of plasmid-free segregants ([@B22]).

The *cfr* context (6,098 bp) was located between *orf7* and *orf14* (*orf39* and *orf40* of pRE25) and consisted of the *cfr* gene flanked by two IS*Enfa5* elements, inserted in turn into the *lnu*(E) gene. The same genetic context of *cfr* \[including the direct repeats and the *lnu*(E) gene\] has been reported in China in a plasmid from a *Streptococcus suis* isolate from an apparently healthy pig ([@B36]) and in Italy in an MRSA isolated from a patient with cystic fibrosis ([@B1]), with *cfr* being untransferable in both instances. Very recently, the *cfr* gene, flanked by only one IS*Enfa5*, inserted upstream, has been described in a chromosomal fragment shared by three pig isolates of *Staphylococcus sciuri* ([@B12]).

PCR assays, using primer pairs targeting regions flanking the *optrA* and the *cfr* contexts (**Figure [1](#F1){ref-type="fig"}**), and sequencing experiments confirmed that both genes could be excised leaving one of the two flanking genes (IS*Efa15* or IS*Enfa5*, respectively) at the excision sites.

Transferability of the *optrA* and *cfr* Genes and Curing of *E. faecium* E35048 From pE35048-oc
------------------------------------------------------------------------------------------------

Repeated attempts of conjugation and transformation assays failed to demonstrate any *optrA* or *cfr* transfer from *E. faecium* E35048 to enterococcal recipients. The partial deletion of *oriT* and the lack of the rolling-circle replication protein might be responsible for the non-conjugative behavior of pE35048-oc compared to pRE25 ([@B31]).

An *optrA*- and *cfr*-negative isogenic strain of *E. faecium* E35048 was obtained after three passages on BHA at 42°C. It was subjected to WGS. Compared to the wild type, it disclosed complete loss of pE35048-oc.

pE35048-oc vs. Other Plasmids Sharing Co-carriage of *optrA* and *cfr*
----------------------------------------------------------------------

Since this study was started, co-location of *optrA* and *cfr* has been reported in a few additional plasmids, some from pig isolates of *S. sciuri* ([@B20]; [@B12]) and one, pEF12-0805, from a human isolate of *E. faecium* ([@B19]). Comparison of pE35048-oc with the *S. sciuri* plasmids revealed completely unrelated backbones and *optrA* and *cfr* contexts. On the other hand, pE35048-oc was related with pEF12-0805 (accession no. KY579372.1) although with significant differences (**Figure [1](#F1){ref-type="fig"}**). In particular:

\(i\) pE35048-oc and pEF12-0805 share a pRE25-related backbone ([@B31]), but pEF12-0805 is much larger (72,924 bp vs. 41,816 bp) due to the presence of a larger amount of pRE25-related regions, including the pRE25 region spanning from *orf51* to *orf5* (∼12,5 kb) and a rearranged region of pRE25 containing antibiotic resistance genes *aphA*, *aadE*, and *lnu*(B) (∼13 kb). (ii) A ∼4-kb remnant of the *ermA*-carrying transposon Tn*554* ([@B26]) is found only in pEF12-0805. (iii) The *optrA* contexts of the two plasmids are completely different, only the *optrA* gene of pE35048-oc being part of a composite transposon. The absence of insertion sequences makes it unlikely that the *optrA* gene of pEF12-0805 is excisable. Moreover, whereas in pE35048-oc the *optrA* context is found downstream of *erm*(B), the *optrA* gene of pEF12-0805 is associated with the *ermA*-carrying Tn*554* remnant. (iv) Interestingly, the *cfr* contexts of the two plasmids are the same, including some plasmid backbone flanking regions on either side (**Figure [1](#F1){ref-type="fig"}**), suggesting that the two plasmids might be derived from a pRE25-related common ancestor that had initially acquired the mobile *cfr* element. (v) Repeated transfer assays were unsuccessful with both plasmids. Finally, (vi) whereas we obtained a pE35048-oc-cured derivative of our *E. faecium* isolate, curing assays were unsuccessful with *E. faecium* strain F120805 ([@B19]).

The *E. faecium* hosts of the two plasmids belonged to different sequence types and were isolated from different sources. Strain E35048 was recovered in 2015 in Italy from a blood culture, belonged to ST117, exhibited no mutational mechanisms of oxazolidinone resistance, and was vancomycin susceptible. Strain F120805, recovered in 2013 in Ireland from feces and reported to have a linezolid MIC of 8 μg/ml, belonged to ST80, exhibited also mutational mechanisms of oxazolidinone resistance (involving both 23S rRNA and ribosomal protein L3), and was vancomycin resistant (*vanA* genotype). Although belonging to different sequence types, ST80 and ST117 were part of the same clonal group, ST78.

Conclusion
==========

Distinctive findings of the *optrA*- and *cfr*-carrying plasmid pE35048-oc are its relation to the well-known enterococcal plasmid pRE25, shared with plasmid pEF12-0805 ([@B19]); a unique *optrA* context, that has never been described before; and the fact that both the *optrA* and *cfr* contexts are capable of excising to form minicircles. This, in addition to the belonging of *E. faecium* E35048 to ST117, a globally disseminated clone recovered in many European health institutions ([@B17]; [@B35]), might favor the spread of *optrA* and *cfr* in the hospital setting. Under this respect, the *in vitro* non-transferability of pE35048-oc is someway reassuring, although transfer *in vivo* cannot be ruled out. Moreover, at the hospital level, it cannot be excluded that co-carriage of *optrA* and *cfr* by the same plasmid ends up turning into co-spread, as already highlighted with pheromone-responsiveness plasmids ([@B13]), and also in consideration of the very recent finding that, in enterococci, non-conjugative plasmids can be mobilized by co-resident, conjugative plasmids ([@B11]). Co-spread would be a cause for special concern, considering that both *optrA* and *cfr* encode resistance, through diverse mechanisms, to different antibiotics, including last resort agents such as oxazolidinones.
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